Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Daytona Beach, Florida 32117


Purpose:

The purpose of this study is to determine which of two delivery methods of Parathyroid Hormone (PTH) is preferred by patients after 14 days of use for each.


Study summary:

The purpose of this study is to determine which of two delivery methods of PTH is preferred by patients after 14 days of use for each. Patient preference will be determined by means of patient questionnaires at the end of each treatment period and a final questionnaire after both treatment periods are complete. Adverse events will also be collected.


Criteria:

Inclusion Criteria: - Postmenopausal with prior diagnosis of osteoporosis Exclusion Criteria: - Significant health issue - previous use of teriparatide - History of Paget's disease


NCT ID:

NCT02478879


Primary Contact:

Principal Investigator
Hugh Coleman, DO
Convance


Backup Contact:

N/A


Location Contact:

Daytona Beach, Florida 32117
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.